JMP Securities Reiterates Market Outperform Rating on Ironwood Pharmaceuticals (IRWD)

October 1, 2024 6:34 AM EDT Send to a Friend
JMP Securities analyst Jason Butler reiterated a Market Outperform rating and $23.00 price target on Ironwood Pharmaceuticals (NASDAQ: IRWD).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login